SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Despite a recent dip, Robinhood (HOOD) is trending as investors discuss its long-term potential and debate whether the pullback presents a buying opportunity. Community members are weighing the impact of broader market trends, including crypto movements and potential interest rate cuts, on the stock's trajectory. Discussions also include the company's profitability and growth prospects amid market volatility.

Bitmine Immersion Technologies, Inc. is a blockchain technology company, which engages in industrial scale digital asset mining, equipment sales, and hosting operations. It operates through the Cryptocurrency Mining Industry segment. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

BMNR is trending as investors anxiously await earnings, with community members debating whether the report will be positive or negative. Discussions also revolve around institutional investments from firms like Morgan Stanley and ARK Invest, and whether the stock's current price reflects its Ethereum holdings. Some traders express concerns about potential losses, while others see it as a buying opportunity amid overall crypto market volatility.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is trending downwards, with the community citing disappointing guidance and concerns about AI competition despite solid earnings and user growth. Traders are actively discussing whether the stock is oversold or faces further decline, with some pointing to insider selling and a potential management issue. Overall sentiment is bearish, with some arguing the company's value is inflated given the rise of free AI language tools.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending as investors discuss the company's recent earnings beat, with many expressing surprise at the muted market reaction and citing overall market conditions. Despite the positive report, community members are debating whether this indicates a buying opportunity or if concerns about potential dilution will continue to weigh on the stock. Comparisons to other brokerage firms like Robinhood are also driving conversation.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending amidst volatility, with traders reacting to a UBS price target increase alongside concerns about potential overbought conditions after a substantial YTD run. Community discussions are focused on whether the memory market's growth, fueled by AI data centers, will sustain or if a pullback is imminent. Investors are closely watching for insights from Micron's upcoming investor conference and Nvidia's earnings report, which are expected to influence the stock's direction.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending as investors analyze its potential performance amid consumer spending shifts and an evolving economic landscape, with some traders pointing to its defensive nature during market uncertainty. Discussions include its upcoming earnings report, AI integration, and a recent CEO transition. The company's potential for growth in e-commerce and market share is also a key talking point.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending as investors assess the impact of debt and AI investments following a recent selloff. Community discussions revolve around insider trading activity and analyst ratings, with some expressing concerns about the company's strategy. Broader market sentiment and potential impacts from upcoming economic data are also being considered.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is experiencing volatility as investors grapple with conflicting signals, including strong earnings from Nvidia and concerns about lofty valuations in the tech sector. Community sentiment is mixed, with debates around whether a market correction is underway or if a rebound is imminent. Discussions also include the potential impact of factors like unemployment data, Federal Reserve policy, and global liquidity on the market's direction.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending as analysts raise price targets for Nvidia, highlighting the strong demand in the AI sector; some believe SMCI, a key partner, is undervalued. However, community members express concerns about SMCI's management and execution, with some pointing to a significant drop from previous highs. Despite positive sentiment around AI, there are discussions about potential market corrections and the impact of broader economic factors.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending amid ongoing discussion about AI infrastructure and data centers following NVDA's earnings, with community members debating whether the sector is experiencing a bubble. Some are pointing to analyst target price increases and potential for significant revenue growth, while others cite concerns about debt and cash flow. Jim Cramer's negative comments have also fueled discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regencell Bioscience Holdings Limited - RGC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regencell Bioscience Holdings Limited - RGC INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of...

Regencell Bioscience (NASDAQ:RGC) Shares Gap Down - Should You Sell?

Regencell Bioscience (NASDAQ:RGC) Shares Gap Down - Here's What Happened...

Regencell Bioscience (NASDAQ:RGC) Trading Up 10.5% - Time to Buy?

Regencell Bioscience (NASDAQ:RGC) Trading 10.5% Higher - Time to Buy...

<a href="https://stocktwits.com/symbol/RGC">Regencell Bioscience Holdings Ltd</a>. (RGC), a Hong Kong-based nano-cap biotech firm, has emerged as one of the most explosive stocks of 2025, skyrocketing 14,486% year-to-date.The staggering rally has captivated retail traders and propelled the stock into the top trending ranks of healthcare chatter on Stocktwits.Over the past three months, message volume surrounding RGC has surged by 17,600% on Stocktwits, while its follower count has jumped 156%, reflecting some of the most intense engagement seen among small-cap health care stocks.Sentiment has mostly remained bullish over the same period, though cracks of doubt have&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rgc-stock-more-than-triples-this-year/ch7KEpeRbcl">emerged</a> as traders digest the stock’s rise despite no formal news or clear catalysts.<figure class="image"><img style="aspect-ratio:1322/1354;" src="https://news.stocktwits-cdn.com/RGC_YTD_chart_with_sentiment_meter_and_message_volume_as_of_May_29_png_6a489def8e.webp" alt="RGC YTD chart with sentiment meter and message volume as of May 29.png" width="1322" height="1354"><figcaption>RGC YTD chart with sentiment meter and message volume as of May 29. | source: Stocktwits</figcaption></figure>Many retail investors remain wary, with some warning of a looming correction."$RGC one of these days this dumps 99% in [a] single trading session," said one user.<stembedurl>https://stocktwits.com/ItSaulGoodMaan/message/616270456</stembedurl>"$RGC this went up 20,000 % in 3 months, if they didn’t just cure cancer, then this is a scam," said another.<stembedurl>https://stocktwits.com/Lard_ass_piggy/message/616269720</stembedurl>Hong Kong-based Regencell focuses on traditional Chinese medicine (TCM), developing formulas aimed at treating ADHD and autism spectrum disorder (ASD).Despite its mission, the company has yet to commercialize any treatments, apply for regulatory approvals, or secure patents.&nbsp;In its most recent annual filing in October, the firm disclosed net losses of $4.36 million for fiscal 2024 and noted it may “never be profitable.”Insider activity appears to be fueling much of the move. According to media reports, insiders control 81% of the float, limiting public liquidity and potentially amplifying volatility.As of June 30, 2024, Regencell reported $8 million in cash and short-term investments, which it believed was enough to cover expenses for at least the following 12 months. However, it said it will likely need “substantial additional financing” to continue operations.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Regencell Biotech Stock's Mind-Blowing 14,400% YTD Rally Draws Frenzied Retail Interest

Many retail investors remain wary, with some warning of a looming correction in the absence of formal news or clear catalysts.

Equity

Many retail investors remain wary, with some warning of a looming correction in the absence of formal news or clear catalysts.


Regencell Bioscience Holdings Ltd (3,500% Jump in Message Volume)Hong Kong-based Regencell focuses on traditional Chinese medicine for neurocognitive disorders, particularly ADHD and autism. Reports suggest its recent rally was fueled by insider buying, with insiders owning 81% of the company.&nbsp;However, a Stocktwits&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rgc-stock-more-than-triples-this-year/ch7KEpeRbcl">poll</a> indicates retail traders remain skeptical, with some flagging it as a potential pump-and-dump risk.&nbsp;The stock has surged 1,054% this year.GlucoTrack Inc. (2,800% Jump in Message Volume)GlucoTrack develops non-invasive glucose monitoring devices. It announced that safety and performance data from its first-in-human trial of a long-term continuous blood glucose monitoring (CBGM) system will be presented at the 2025 ATTD conference.&nbsp;CEO Paul V. Goode highlighted its potential for real-time glucose monitoring without on-body wearables, calling it a transformative step in diabetes management.&nbsp;GlucoTrack stock is down over 96% year-to-date (YTD).TC Biopharm (Holdings) Plc (1,300% Jump in Message Volume)TC Biopharm&nbsp;<a href="https://stocktwits.com/symbol/TCBP">received</a> a Nasdaq delisting notice due to its share price falling below $1. Trading will be suspended on Monday, with its American depository shares expected to move to OTC Markets.&nbsp;The company is also shifting to a contract development and manufacturing organization (CDMO) model, cutting about 50% of its workforce to reduce operational burn by 55%. This is projected to save $2.1 million in 2025 and $4.2 million annually.&nbsp;The stock is down over 95% YTD.AbbVie Inc. (700% Jump in Message Volume)Erste Group upgraded AbbVie to ‘Buy’ from ‘Hold’, according to The Fly, citing strong sales growth projections through 2029, supported by upcoming product launches. The research firm expects earnings per share (EPS) to rise significantly in 2025, ranging from $12.12 to $12.32.&nbsp;AbbVie recently agreed to acquire a next-gen obesity drug from Denmark-based Gubra A/S for up to $2.2 billion, boosting sentiment.&nbsp;The stock is up over 17.5% YTD.Actinium Pharmaceuticals Inc. (600% Jump in Message Volume)Actinium is launching trials for its drug Actimab-A in combination with Merck’s Keytruda and Bristol Myers Squibb’s Opdivo to treat solid tumors. The trials will include head-to-head studies comparing Actimab-A combinations to standalone treatments.&nbsp;The company also entered a research agreement with Memorial Sloan Kettering to expand Actimab-A’s applications.&nbsp;Actinium stock is up over 22% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A person examines financial data on a screen displaying a graph with upward and downward trends, using a pen to trace the line chart. | Representative Image: Getty Images

Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week

Investors reacted to insider buying, clinical trial updates, and strategic business shifts that happened in the week ended March 21, 2025.

Regencell Bioscience Holdings Ltd. shares have been on a tear recently, more than tripling in value even before the first quarter of 2025 has ended. Retail traders, however, are not overly bullish about this stock.Hong Kong-based Regencell focuses on the research, development, and commercialization of traditional Chinese medicine, targeting neurocognitive disorders and degeneration, particularly attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).According to several media&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/insiders-regencell-bioscience-holdings-limited-120457560.html">reports</a>, the recent rally has been driven mainly by buying from insiders, who own 81% of the company.The stock’s&nbsp;surge also comes amid a broader rally in Chinese stocks, driven by hopes of economic stimulus from Xi Jinping’s government.Koyfin data shows that only three institutional investors have a combined stake of a little over $156,000 in the company.A Stocktwits poll gauging retail sentiment on Regencell showed that 52% of nearly 1,000 respondents opted to stay away from the stock as it was "too risky for me," while 31% suggested they were buying it now.&nbsp;Another 12% said they were selling and taking profits, while 5% claimed to have "caught the move early."<figure class="image"><img style="aspect-ratio:1316/654;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/RGC_Stocktwits_poll_results_png_e989704d45.webp" alt="RGC Stocktwits poll results .png" width="1316" height="654"><figcaption>RGC Stocktwits poll results</figcaption></figure>Over the past three months, Regencell's following on Stocktwits has grown by 48% while message volume has soared by 30,000%.One bullish user claimed they bought Regencell stock when it was less than half its last close.<stembedurl>https://stocktwits.com/CryptoSenderX/message/607994621</stembedurl>However, a skeptic argued that RGC actually moved up "on no news. I'm shorting and waiting for the rug pull."<stembedurl>https://stocktwits.com/SmoothD/message/608057630</stembedurl>Regencell has not generated revenue or a profit ever since it went public on the Nasdaq in July 2021.&nbsp;It has a low float of about 802,000 shares, making it a highly volatile stock.One Stocktwits user expressed strong skepticism, saying, "This reeks of a scam so bad. Hong Kong biotech with 12 full-time employees. Chinese medicine ancient herbs for ADHD. This will collapse."<stembedurl>https://stocktwits.com/jimmieB/message/608370796</stembedurl>According to Koyfin, no analysts currently cover the stock on Wall Street. The stock ended Monday 46% higher and jumped another 42% in after-hours trading.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Regencell Bioscience Stock Is Up Over 260% This Year — Are Retail Traders Riding The Wave Or Watching From The Sidelines?

The Hong Kong-based company focuses on researching, developing, and commercializing traditional Chinese medicine, targeting neurocognitive disorders and degeneration.

12 titoli sanitari in movimento, sessione regolare del 22/03/2024

Titoli in rialzo
Il titolo IMAC Hldgs (NASDAQ:BACK) salito del 93,02% a 2,49 dollari durante la sessione regolare di venerd .
Il titolo Regencell Bioscience (NASDAQ:RGC) ha osservato un incremento...

12 acciones de salud en movimiento en la sesi n intrad a del 11/03/2024

Acciones al alza
Regencell Bioscience (NASDAQ:RGC) experimentaron un repunte del 130,88% para establecerse en los 10,39 d lares durante la sesi n del regular del lunes.
TC BioPharm (Holdings...

Regencell Bioscience Holdings Ltd trading resumes

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Regencell Bioscience Holdings Ltd trading halted, volatility trading pause

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

RGC
Regencell Bioscience Holdings Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RGC News

RGCRegencell Bioscience Holdings Ltd